rs1060502971
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PM5PP2PP5
The NM_015915.5(ATL1):c.461A>G(p.Gln154Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q154E) has been classified as Likely pathogenic.
Frequency
Consequence
NM_015915.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATL1 | NM_015915.5 | c.461A>G | p.Gln154Arg | missense_variant | Exon 4 of 14 | ENST00000358385.12 | NP_056999.2 | |
ATL1 | NM_001127713.1 | c.461A>G | p.Gln154Arg | missense_variant | Exon 5 of 14 | NP_001121185.1 | ||
ATL1 | NM_181598.4 | c.461A>G | p.Gln154Arg | missense_variant | Exon 4 of 13 | NP_853629.2 | ||
ATL1 | XM_047431430.1 | c.461A>G | p.Gln154Arg | missense_variant | Exon 5 of 15 | XP_047287386.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 3A Pathogenic:1Uncertain:1
This sequence change replaces glutamine with arginine at codon 154 of the ATL1 protein (p.Gln154Arg). The glutamine residue is highly conserved and there is a small physicochemical difference between glutamine and arginine. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a ATL1-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C35"). However, a different missense substitution at this codon (p.Gln154Glu) is reported to be deleterious (PMID: 20932283). This indicates that the p.Gln154 residue is important for ATL1 protein function. In summary, this variant is a novel missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. -
The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product [3Cnet: 0.63 (>=0.6, sensitivity 0.72 and precision 0.9)]. Same nucleotide change resulting in same amino acid change (ClinVar ID: VCV000410596) and a different missense change at the same codon (p.Gln154Glu / PMID: 20932283) have been previously reported to be associated with ATL1 related disorder. Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. -
Abnormal pyramidal sign Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at